Concepedia

Jamie N. Connarn

JN

15

Publications

3K

Citations

15

H-Index

2012

Active since

Affiliations

University of Michigan(Current)

Bristol-Myers Squibb (United States)

Massachusetts General Hospital

Hackensack University Medical Center

Dana-Farber Cancer Institute

Jamie N. Connarn is an author at University of Michigan specializing in tumor immunology, health sciences, and t cell immunity.

Top concepts

HealthMedicineOncologyImmunologyAutoimmunityImmunotherapyTumor ImmunityClinical TrialsImmuno-oncologyT Cell Immunity

Publications per year

2012–2023

15

Publications

15

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

Nikhil C. Munshi, Larry D. Anderson, Nina Shah et al. · New England Journal of Medicine · 2021 · 2.3K citations · Full text

Analogues of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, As Anti-Cancer Agents

Xiaokai Li, Sharan R. Srinivasan, Jamie N. Connarn et al. · ACS Medicinal Chemistry Letters · 2013 · 154 citations · Full text

Idecabtagene vicleucel (ide-cel; bb2121), a BCMA-targeted CAR T-cell therapy, in patients with relapsed and refractory multiple myeloma (RRMM): Initial KarMMa results.

Nikhil C. Munshi, Larry D. Anderson, Nina Shah et al. · Journal of Clinical Oncology · 2020 · 120 citations

Immunology, Immune Regulation, Immunoediting +22

Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study

William K. Kelly, Daniel C. Danila, Chia‐Chi Lin et al. · Cancer Discovery · 2023 · 74 citations · Full text

Trastuzumab resistance induces EMT to transform HER2+ PTEN− to a triple negative breast cancer that requires unique treatment options

Joseph Burnett, Hasan Körkaya, Maria Ouzounova et al. · Scientific Reports · 2015 · 61 citations · Full text

Rows per page

1–5 of 15